Literature DB >> 1506876

Hypoxic neuropathy versus diabetic neuropathy. An electrophysiological study in rats.

P H Hendriksen1, P L Oey, G H Wieneke, A C van Huffelen, W H Gispen.   

Abstract

In the experimental rat model of diabetes a slowing of nerve conduction velocity and a resistance to ischemic conduction failure have been found as an indication of polyneuropathy. The same electrophysiological abnormalities have been demonstrated in a model in which healthy rats are kept under hypoxic conditions (10% O2) for a 10-week period. Two factors are held responsible for the development of diabetic polyneuropathy: metabolic deterioration and hypoxia. However, until now the relative roles of metabolic deterioration and hypoxia in the development of polyneuropathy have not been settled. To test both explanations further with more sophisticated electrophysiological techniques, the H-reflex (motor and sensory NVC) and the stimulated SF-EMG (measures terminal nerve branch and neuromuscular transmission) were measured in 3 groups of 10 rats, a healthy control group, a diabetic group, and a hypoxic group, every 5 weeks, for 6 months. In the control rats an age-related increase in motor and sensory conduction velocity was found, whereas in the diabetic rats as well as in the hypoxic rats a marked decrease in sensory and a slight decrease in motor nerve conduction velocity was observed. The jitter measured in the stimulated SF-EMG was significantly increased in both the diabetic and the hypoxic group. The results of the present study support the possible role of hypoxia, in addition to metabolic factors, in the development of experimental diabetic neuropathy.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1506876     DOI: 10.1016/0022-510x(92)90015-d

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  4 in total

1.  Amelioration by the Ca2+ antagonist, nimodipine of an existing neuropathy in the streptozotocin-induced, diabetic rat.

Authors:  A C Kappelle; B Bravenboer; T van Buren; J Traber; D W Erkelens; W H Gispen
Journal:  Br J Pharmacol       Date:  1993-03       Impact factor: 8.739

2.  Beneficial effect of the Ca2+ antagonist, nimodipine, on existing diabetic neuropathy in the BB/Wor rat.

Authors:  A C Kappelle; G Biessels; B Bravenboer; T van Buren; J Traber; D J de Wildt; W H Gispen
Journal:  Br J Pharmacol       Date:  1994-03       Impact factor: 8.739

3.  Modeling Hypoxia-Induced Neuropathies Using a Fast and Scalable Human Motor Neuron Differentiation System.

Authors:  Laura I Hudish; Andrew Bubak; Taylor M Triolo; Christy S Niemeyer; David S Lorberbaum; Lori Sussel; Maria Nagel; J Matthew Taliaferro; Holger A Russ
Journal:  Stem Cell Reports       Date:  2020-05-07       Impact factor: 7.765

4.  Relationship of Vascular Factors on Electrophysiologic Severity of Diabetic Neuropathy.

Authors:  Jeong-Won Hwang; Sung-Bom Pyun; Hee Kyu Kwon
Journal:  Ann Rehabil Med       Date:  2016-02-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.